Working with a health system, the investigators will recruit practices to participate in the pilot study, consent and enroll patients with major depressive disorder, and collect the PHQ-9 from those patients at three timepoints (baseline, 6 months post-enrollment, and 12 months post-enrollment). The PHQ-9 will be captured either at an office visit or directly from patients. The investigators will build and implement an open-source SMART on FHIR app to collect key data from the EHR, combine that data with the PHQ-9 results, and present the measurements back to the clinicians. The investigators will then obtain feedback from clinicians on the value and usefulness of the app.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Death from suicide
Timeframe: 12-month intervals
Improvement in Depressive Symptoms: Remission
Timeframe: Baseline
Improvement in Depressive Symptoms: Remission
Timeframe: 6 months post baseline (+/- 60 days)
Improvement in Depressive Symptoms: Remission
Timeframe: 12 months post baseline (+/- 60 days)
Improvement in Depressive Symptoms: Response
Timeframe: Baseline
Improvement in Depressive Symptoms: Response
Timeframe: 6 months post baseline (+/- 60 days)
Improvement in Depressive Symptoms: Response
Timeframe: 12 months post baseline (+/- 60 days)
Worsening in Depressive Symptoms: Recurrence
Timeframe: Baseline
Worsening in Depressive Symptoms: Recurrence
Timeframe: 6 months post baseline (+/- 60 days)
Worsening in Depressive Symptoms: Recurrence
Timeframe: 12 months post baseline (+/- 60 days)
Adverse Events
Timeframe: Baseline
Adverse Events
Timeframe: 6 months post baseline (+/- 60 days)
Adverse Events
Timeframe: 12 months post baseline (+/- 60 days)
Suicide Ideation and Behavior
Timeframe: Baseline
Suicide Ideation and Behavior
Timeframe: 6 months post baseline (+/- 60 days)
Suicide Ideation and Behavior
Timeframe: 12 months post baseline (+/- 60 days)